Olfactory receptor 5B21 drives breast cancer metastasis

Olfactory receptors (ORs), responsible for the sense of smell, play an essential role in various physiological processes outside the nasal epithelium, including cancer. In breast cancer, however, the expression and function of ORs remain understudied. We examined the significance of OR transcript abundance in primary and metastatic breast cancer to the brain, bone, and lung. Although 20 OR transcripts were differentially expressed in distant metastases, OR5B21 displayed an increased transcript abundance in all three metastatic sites compared with the primary tumor. Knockdown of OR5B21 significantly decreased the invasion and migration of breast cancer cells as well as metastasis to different organs especially the brain, whereas increasing of OR5B21 transcript abundance had the opposite effect. Mechanistically, OR5B21 expression was associated with epithelial to mesenchymal transition through the STAT3/NF-kappa B/CEBPb signaling axis. We propose OR5B21 (and potentially other ORs) as a novel oncogene contributing to breast cancer metastasis and a potential target for adjuvant therapy.

Automated summary

The study found that in breast cancer metastasis, OR5B21 showed increased transcript abundance in distant metastatic sites, and its knockdown significantly reduced invasion and migration of cancer cells. OR5B21 expression was associated with epithelial to mesenchymal transition through the STAT3/NF-kappa B/CEBPb signaling axis.